You may also like
Baxter Initiates Worldwide Voluntary Recall Of Select Lots Of 5 percent Dextrose Injection, USP And 0.9 percent Sodium Chloride Injection, USP Intravenous (IV) Solutions
Baxter International Inc. announced today it has initiated a voluntary recall to the hospital/user level of one lot of 5 percent Dextrose Injection, USP and four lots of 0.9 percent Sodium Chloride Injection, USP due to particulate matter found in the solutions. Injecting a product containing particulate matter may result in blockages of blood vessels, which can result in stroke, heart attack or damage to other organs such as the kidney or liver.
The Safety and Efficacy of Dexmedetomidine for Postoperative Sedation in the Cardiac Surgery Intensive Care Unit
In this study we hypothesized that routine use of dexmedetomidine allows early extubation in cardiac surgery patients.
ADA: Autologous Platelet Gel Effectively Treats Diabetic Plantar Wounds
Use of the autologous platelet gel, AuTolo-Gel, to treat non-healing diabetic plantar surface wounds provides good volume reduction and wound healing, researchers […]